retatrutide definition Retatrutide—A Game Changer in Obesity Pharmacotherapy RETATRUTIDE (RETA) – Research Peptide

TB-500 Research peptide

December 27, 2024: FDA Posts Updates to Zepbounds Drug Label to Include More Information About Acute Pancreatitis Due to results from two clinical trials for Zepbound, the FDA has posted drug safety-related labeling changes for the weight-loss drug

What approval requires: Completion of Phase 3 clinical trials demonstrating safety and efficacy, submission of a New Drug Application (NDA) to the FDA, review and approval process that typically takes 6-12 months after submission

These usually decrease over time

Some research suggests that obesity and metabolic syndrome may be associated with increased inflammation and other factors that could potentially influence neurological health, including seizure control in some individuals